2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Comparing and Quantifying the Efficiency of Cocrystal Screening Methods for Praziquantel

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pharmaceutical cocrystals are highly interesting due to their effect on physicochemical properties and their role in separation technologies, particularly for chiral molecules. Detection of new cocrystals is a challenge, and robust screening methods are required. As numerous techniques exist that differ in their crystallization mechanisms, their efficiencies depend on the coformers investigated. The most important parameters characterizing the methods are the (a) screenable coformer fraction, (b) coformer success rate, (c) ability to give several cocrystals per successful coformer, (d) identification of new stable phases, and (e) experimental convenience. Based on these parameters, we compare and quantify the performance of three methods: liquid-assisted grinding, solvent evaporation, and saturation temperature measurements of mixtures. These methods were used to screen 30 molecules, predicted by a network-based link prediction algorithm (described in Cryst. Growth Des. 2021, 21(6), 3428–3437) as potential coformers for the target molecule praziquantel. The solvent evaporation method presented more drawbacks than advantages, liquid-assisted grinding emerged as the most successful and the quickest, while saturation temperature measurements provided equally good results in a slower route yielding additional solubility information relevant for future screenings, single-crystal growth, and cocrystal production processes. Seventeen cocrystals were found, with 14 showing stability and 12 structures resolved.

          Abstract

          Detection of new cocrystals is key for the pharmaceutical industry, and efficient screening methods are required. The results of a cocrystal screening campaign for praziquantel are studied to compare thoroughly the advantages and drawbacks of three screening methods used: liquid-assisted grinding, solvent evaporation, and saturation temperature measurements. With the definition of quantified values and the calculation of comparison parameters, it is possible to compare quantitatively the efficiencies of screening methods.

          Related collections

          Most cited references69

          • Record: found
          • Abstract: not found
          • Article: not found

          Polymorphs, Salts, and Cocrystals: What’s in a Name?

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Pharmaceutical cocrystals: along the path to improved medicines

            Cocrystals, a long known but understudied class of crystalline solids, have attracted interest from crystal engineers and pharmaceutical scientists in the past decade and are now an integral part of the preformulation stage of drug development. Cocrystals, a long known but understudied class of crystalline solids, have attracted interest from crystal engineers and pharmaceutical scientists in the past decade and are now an integral part of the preformulation stage of drug development. This is largely because cocrystals that contain a drug molecule, pharmaceutical cocrystals, can modify physicochemical properties without the need for covalent modification of the drug molecule. This review presents a brief history of cocrystals before addressing recent advances in design, discovery and development of pharmaceutical cocrystals that have occurred since an earlier review published in 2004. We address four aspects of cocrystals: nomenclature; design using hydrogen-bonded supramolecular synthons; methods of discovery and synthesis; development of pharmaceutical cocrystals as drug products. Cocrystals can be classified into molecular cocrystals (MCCs) that contain only neutral components (coformers) and ionic cocrystals (ICCs), which are comprised of at least one ionic coformer that is a salt. That cocrystals, especially ICCs, offer much greater diversity in terms of composition and properties than single component crystal forms and are amenable to design makes them of continuing interest. Seven recent case studies that illustrate how pharmaceutical cocrystals can improve physicochemical properties and clinical performance of drug substances, including a recently approved drug product based upon an ICC, are presented.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?

              The evolution of crystal engineering into a form of supramolecular synthesis is discussed in the context of problems and opportunities in the pharmaceutical industry. Specifically, it has become clear that a wide array of multiple component pharmaceutical phases, so called pharmaceutical co-crystals, can be rationally designed using crystal engineering, and the strategy affords new intellectual property and enhanced properties for pharmaceutical substances.
                Bookmark

                Author and article information

                Journal
                Cryst Growth Des
                Cryst Growth Des
                cg
                cgdefu
                Crystal Growth & Design
                American Chemical Society
                1528-7483
                1528-7505
                25 August 2022
                07 September 2022
                : 22
                : 9
                : 5511-5525
                Affiliations
                []EPSRC Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallization (CMAC), University of Strathclyde, Technology and Innovation Centre , 99 George Street, Glasgow G1 1RD, U.K..
                []Institute for Molecules and Materials, Radboud University , Heyendaalseweg 135, 6525AJ Nijmegen, The Netherlands
                [§ ]Department of Chemical and Process Engineering, University of Strathclyde , James Weir Building, 75 Montrose Street, Glasgow G1 1XJ, U.K.
                []Laboratoire Sciences et Méthodes Séparatives, Université de Rouen Normandie , Place Emile Blondel, 76821 Mont Saint Aignan Cedex, France
                Author notes
                Author information
                https://orcid.org/0000-0003-3066-0491
                https://orcid.org/0000-0002-1343-4102
                https://orcid.org/0000-0001-6152-640X
                https://orcid.org/0000-0002-5817-3479
                https://orcid.org/0000-0003-0118-2160
                Article
                10.1021/acs.cgd.2c00615
                9460446
                6ec5af13-cc5a-4509-a79c-aa7310ffabc6
                © 2022 The Authors. Published by American Chemical Society

                Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained ( https://creativecommons.org/licenses/by/4.0/).

                History
                : 31 May 2022
                : 15 August 2022
                Funding
                Funded by: Engineering and Physical Sciences Research Council, doi 10.13039/501100000266;
                Award ID: EP/I033459/1
                Categories
                Article
                Custom metadata
                cg2c00615
                cg2c00615

                Materials technology
                Materials technology

                Comments

                Comment on this article